BP000158-CYT-212: Recombinant Human IL-5
Source: E. coli-derived.
The ED50 as determined by the dose-dependant stimulation of the proliferation of TF-1 cells was found to be < 0.15 ug/ml, corresponding to a Specific Activity of 6.7 MIU/mg.
Purity > 98%, by SDS-PAGE and RP-HPLC.BP000158-CYT-387: Recombinant Rat IL-5
Source: E. coli-derived.
The ED50 range=0.3-1.0 ug/ml as determined by the dose-dependant stimulation of the proliferation of BCL-1 cells.
Purity > 95%, by SDS-PAGE and RP-HPLC.BP000158-CYT-689: Recombinant Mouse IL-5
Source: E. coli-derived.
The ED50 as determined by the dose-dependant stimulation of the proliferation of TF-1 cells was found to be 1.7 ug/ml, corresponding to a specific activity of 588,235.3 IU/mg.
Purity > 97%, by SDS-PAGE and RP-HPLC.BP000176-CYT-221: Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Protein
Source: E. coli-derived.
The ED50 as determined by the dose-dependant stimulation of the proliferation of human TF-1 cells (human erythroleukemic indicator cell line) is < 0.1 ng/ml, corresponding to a Specific Activity of 11,100,000 IU/mg.
Purity: > 98% by SDS-PAGE and RP-HPLC.BP000176-CYT-324: Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Protein, Pichia
Source:Pichia Pastoris-derived.
The ED50 as determined by the dose-dependant stimulation of the proliferation of human TF-1 cells (human erythroleukemic indicator cell line) is < 0.183 ng/ml, corresponding to a Specific Activity of 5.5 MIU/mg.
Purity: > 97% by SDS-PAGE and RP-HPLC.BP000176-CYT-222: Recombinant Mouse Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Protein
Source: E. coli-derived.
N-terminal sequence analysis: Met-Ala-Pro-Thr-Arg.
The ED50 as determined by the dose-dependant stimulation of the proliferation of murine FDC-P1 cell line is < 0.2 ng/ml, corresponding to a Specific Activity of 5,000,000 IU/mg.
Purity: > 98% by SDS-PAGE and RP-HPLC.BP000176-CYT-395: Recombinant Rat Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Protein
Source: E. coli-derived.
The ED50 is 0.001-0.01 ng/ml corresponding to a specific activity of 100-1,000 MIU/mg, determined by the dose dependent proliferation of murine MC/9 cells.
Purity: > 95% by SDS-PAGE and RP-HPLC.BP000157-CYT-097: Recombinant Human Interleukin-4 (IL-4) Protein, HEK
Source: HEK-derived.
The activity was determined by the dose dependent stimulation of the proliferation of human TF-1 cells (human erythroleukemic indicator cell line) and is typically 0.1-0.5 ug/ml.
Purity: > 95% as obsereved by SDS-PAGE.BP000157-CYT-172: Recombinant Rhesus Macaque Interleukin-4 (IL-4) Protein
Source: E. coli-derived.
The ED50 as determined by the dose-dependent stimulation of TF1 cells is less than 0.2 ng/ml, corresponding to a specific activity of >5.0×106 IU/mg.
Purity: > 97.0% as determined by RP-HPLC and by SDS-PAGE.BP000157-CYT-398: Recombinant Porcine Interleukin-4 (IL-4) Protein
Source: E. coli-derived.
The ED50 range= 1 to 4 ng/ml corresponding to a Specific Activity of 0.25-1 MIU/mg. The biological activity is determined by measuring the dose dependent proliferation of human TF-1 cells. A concentration range of 0.1 to 10.0 ng/ml is effective for most in vitro applications.
Purity: > 95% by SDS-PAGE and RP-HPLC.